We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$830B
AUM Growth
-$35.6B
Cap. Flow
+$7.17B
Cap. Flow %
0.86%
Top 10 Hldgs %
17.54%
Holding
7,378
New
607
Increased
2,657
Reduced
2,665
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Healthcare 10.88%
3 Financials 10.81%
4 Consumer Discretionary 8.58%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFRX icon
6226
InflaRx
IFRX
$296M
$1K ﹤0.01%
538
-454
-46% -$1.41K
IXP icon
6227
iShares Global Comm Services ETF
IXP
$569M
$1K ﹤0.01%
10
-19
-66% -$1.44K
JWEL icon
6228
Jowell Global
JWEL
$7.51M
$1K ﹤0.01%
38
-16
-30% -$821
KTTA icon
6229
Pasithea Therapeutics
KTTA
$16M
$1K ﹤0.01%
50
LARK icon
6230
Landmark Bancorp
LARK
$197M
$1K ﹤0.01%
27
LTPZ icon
6231
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$745M
$1K ﹤0.01%
10
-330
-97% -$27.7K
MBRX icon
6232
Moleculin Biotech
MBRX
$4.06M
$1K ﹤0.01%
+2
New +$1.15K
NERV icon
6233
Minerva Neurosciences
NERV
$187M
$1K ﹤0.01%
+81
New +$497
NKTR icon
6234
PUT
Nektar Therapeutics
NKTR
$2.57B
$1K ﹤0.01%
7
-3,580
-100% -$530K
NOMD icon
6235
Nomad Foods
NOMD
$1.68B
$1K ﹤0.01%
24
-28,001
-100% -$680K
PALI icon
6236
Palisade Bio
PALI
$375M
$1K ﹤0.01%
+1
New +$808
PHGE icon
6237
BiomX
PHGE
$1.67M
$1K ﹤0.01%
+3
New +$892
PHIO icon
6238
Phio Pharmaceuticals
PHIO
$12.7M
$1K ﹤0.01%
14
+11
+367% +$1.05K
PLX icon
6239
Protalix BioTherapeutics
PLX
$190M
$1K ﹤0.01%
+1,127
New +$1.03K
PROV icon
6240
Provident Financial
PROV
$113M
$1K ﹤0.01%
32
PST icon
6241
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.5M
$1K ﹤0.01%
+50
New +$861
PXH icon
6242
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$1K ﹤0.01%
+67
New +$1.46K
RFV icon
6243
Invesco S&P MidCap 400 Pure Value ETF
RFV
$343M
$1K ﹤0.01%
9
RVPH
6244
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$1K ﹤0.01%
+17
New +$678
DCOY
6245
Decoy Therapeutics
DCOY
$1.88M
0
STRS
6246
DELISTED
STRATUS PPTYS INC
STRS
$1K ﹤0.01%
20
-1,860
-99% -$70.5K
TCI icon
6247
Transcontinental Realty Investors
TCI
$312M
$1K ﹤0.01%
35
-35
-50% -$1.37K
TCRX icon
6248
TScan Therapeutics
TCRX
$52.3M
$1K ﹤0.01%
+361
New +$1.56K
TEO icon
6249
Telecom Argentina
TEO
$5.75B
$1K ﹤0.01%
97
+12
+14% +$63
UBFO
6250
DELISTED
United Security Bancshares
UBFO
$1K ﹤0.01%
93

Similar funds

JP Morgan Chase's Q1 2022 Portfolio in Review

As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
  • JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
  • JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
  • JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
  • JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.